

ASSOCIATED PRESS
Vice President Dick Cheney’s trip to China next week to talk with leaders about high-stakes world issues like terrorism and nuclear tensions has an additional purpose — to make a pitch for Westinghouse’s reactor technology.
At stake could be billions of dollars in business in coming years and thousands of American jobs. The initial installment of four reactors, costing $1.5 billion apiece, would also help narrow the huge U.S. trade deficit with China.
China’s latest economic plan anticipates more than doubling its electricity output by 2020 and the Chinese government, facing enormous air pollution problems, is looking to shift some of that away from coal-burning plants. Its plan calls for building as many as 32 large 1,000-megawatt reactors over the next 16 years.
No one has ordered a new reactor in the United States in three decades and the next one, if it comes, is still years away. So, China is being viewed by the U.S. industry as a potential bonanza.
Mr. Cheney’s three-day visit to Beijing and Shanghai next week is part of a weeklong trip to Asia. He will focus on terrorism and nuclear tensions over North Korea, but he also is expected to talk up U.S. reactor technology, according to industry and government sources.
A senior administration official, briefing reporters about the trip, said Mr. Cheney will not “pitch individual commercial transactions.” But he intends to make clear “we support the efforts of our American companies” and general access to China’s markets, said the official, speaking on the condition of anonymity.
Some critics are concerned about such technology transfers.
“This pitch could not be more poorly timed,” Henry Sokolski, executive director of the Nonproliferation Policy Education Center, told a hearing of the House International Relations Committee recently.
Citing recent Chinese plans to help Pakistan build two large reactors that are capable of producing plutonium, he said it is not the time for China to be rewarded with new reactor technology. U.S. officials said the Chinese have given adequate assurances that such sales will not pose a proliferation risk.
Bid solicitations for four new reactors are expected to be issued by the Chinese within months.
The leading competitors are U.S.-based Westinghouse Electric Co. and a French rival, Areva, which is peddling its next-generation reactor built by its Framatome subsidiary.
Westinghouse is putting its hopes on its 1,100 megawatt AP1000 reactor, an advanced design that is still waiting approval from the Nuclear Regulatory Commission before it can be built in the United States. Westinghouse, owned by the British nuclear firm BNFL, is the only U.S.-based manufacturer of a pressurized water reactor, the type of design China has said it wants to pursue.
“Clearly the China market is very important to the industry and a supplier like Westinghouse,” said Vaughn Gilbert, a spokesman for the Pittsburgh-based reactor vendor. “The Chinese market is one that we’re pursuing.”
Each of the AP1000 reactors is expected to cost about $1.5 billion. “We would assume there would be more than one order,” Mr. Gilbert said, since China has indicated it wants a standardized design across its reactor program. A successful bid could mean 5,000 American jobs, Mr. Gilbert said.
View Entire StoryPresident is violating religious freedom for an ineffective plan

By Rowan Scarborough - The Washington Times
Navy Secretary Ray Mabus, under fire from Congress and veterans for naming ships after fellow ...

By Tim Devaney - The Washington Times
Rick Berman has a black baseball cap with the words “Dr. Evil” in his K ...

By Sean Lengell and Dave Boyer - The Washington Times
Congressional leaders told their lawmakers Tuesday night they’ve reached a tentative deal to extend the ...
Independent voices from the TWT Communities

Immerse yourselves in the genius insights of a high school sports freak and statistical wizard who knows it all. Or at least thinks he does.

Health care reform, organized medicine, physician practice management, and patient care--a real time look at the challenges facing doctors and patients in America today.